Publication | Closed Access
Randomized Phase 3 Study of Panitumumab With FOLFIRI vs. FOLFIRI Alone as Second-Line Treatment in Patients With Metastatic Colorectal Cancer
23
Citations
0
References
2010
Year
Second-line TreatmentGastrointestinal OncologyMedicinePathologyColorectal CancerMetastatic Colorectal CancerCancer TreatmentOncologyRadiation OncologyPhase 3
No additional data available for this publication yet. Check back later!